Muscle fiber type-specific defects in insulin signal transduction to glucose transport in diabetic GK rats

Diabetes

Volumn 48, Issue 3, 1999, Pages 664-670

  Song, Xiao Mei ^a   Kawano, Yuichi ^a   Krook, Anna ^a   Ryder, Jeffrey W ^a   Efendic, Suad ^a   Roth, Richard A ^b   Wallberg Henriksson, Harriet ^a   Zierath, Juleen R ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHLORIZIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; ENZYME ANALYSIS; GLUCOSE TRANSPORT; MALE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

EID: 0005828771     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.3.664     Document Type: Article

References (50)

1. Nolan JJ, Freidenberg G, Henry R, Reichart D, Olefsky JM: Role of human skeletal muscle insulin receptor kinase in the in vivo insulin resistance of non-insulin-dependent diabetes mellitus and obesity. J Clin Endocrinol Metab 78:471-477, 1994
2. Nyombia BL, Ossowski VM, Bogardus C, Mott DM: Insulin-sensitive tyrosine kinase relationship with in vivo insulin action in humans. Am J Physiol 258:E964-E974, 1990
3. Maegawa H, Shigeta Y, Egawa K, Kobayashi M: Impaired autophosphorylation of insulin receptors from abdominal skeletal muscles in nonobese subjects with NIDDM. Diabetes 40:815-819, 1991
4. Saad MJA, Folli F, Kahn JA, Kahn CR: Modulation of insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of dexamethasone-treated rats. J Clin Invest 92:2065-2072, 1993
5. Saad MJA, Araki E, Miralpeix M, Rothenberg PL, White MF, Kahn CR: Regulation of insulin receptor substrate-1 in liver and muscle of animal models of insulin resistance. J Clin Invest 90:1838-1849, 1992
6. Björnholm M, Kawano Y, Lehtihet M, Zierath JR: Insulin receptor substrate-phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation. Diabetes 46:524-427, 1997
7. Goodyear LJ, Giorgino F, Sherman LA, Carey J, Smith RJ, Dohm GL: Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J Clin Invest 95:2195-2204, 1995
8. Folli F, Saad MJA, Backer JM, Kahn CR: Regulation of phosphatidylinositol 3-kinase activity in liver and muscle of animal models of insulin-resistant and insulin-deficient diabetes mellitus. J Clin Invest 92:1787-1794, 1993
9. Heydrick SJ, Jullien D, Gautier N, Tanti JF, Giorgetti S, Van Obberghen E, Marchand-Brustel Y: Defect in skeletal muscle phosphatidylinositol-3-kinase in obese insulin-resistant mice. J Clin Invest 91:1358-1366, 1993
10. Zierath JR, Houseknecht KL, Gnudi L, Kahn BB: High-fat feeding impairs insulin-stimulated GLUT4 recruitment via an early insulin signaling defect. Diabetes 46:215-223, 1997
11. Kahn CR: Banting Lecture: insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 43:1066-1084, 1994
12. Ariano MA, Armstrong RB, Edgerton VR: Hindlimb muscle fiber populations of five animals. J Histochem 21:51-55, 1973
13. Nemeth P, Pette D: Succinate dehydrogenase activity in fibers classified by myosin ATPase in three hindlimb muscles of rat. J Physiol (Lond) 320:73-80, 1979
14. Nolte LA, Galuska D, Martin IK, Zierath JR, Wallberg-Henriksson H: Elevated free fatty acid levels inhibit glucose phosphorylation in slow-twitch rat skeletal muscle. Acta Physiol Scand 151:51-59, 1994
15. Kriketos AD, Pan DA, Sutton JR, Hoh JF, Baur LA, Cooney GJ, Jenkins AB, Storlin LH: Relationship between muscle membrane lipids, fiber type, and enzyme activities in sedentary and exercised rats. Am J Physiol 269:R1154-R1162, 1995
16. Saltin B, Gollnick PD: Skeletal muscle adaptability: significance for metabolism and performance. Handbook of Physiology. Peachy LD, Ed. Oxford, Oxford University, 1983, p. 555-631
17. Kraegen EW, James DE, Storlien LH, Burleigh KM, Crisholm DJ: In vivo insulin resistance in individual peripheral tissues of the high fat fed rat: assessment by euglycaemic clamp plus deoxyglucose administration. Diabetologia 29:192-198, 1986
18. Scheen AJ, Lefebvre PJ: Assessment of insulin resistance in vivo: application to the study of type 2 diabetes. Horm Res 38:19-17, 1992
19. Zierath JR, He L, Gumà A, Odegaard Whalström E, Klip A, Wallberg-Henriksson H: Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM. Diabetologia 39:1180-1189, 1996
20. Rossetti L, Smith D, Schulman GI, Papachristou D, DeFronzo RA: Correction of hyperglycemia with Phlorizin normalizes tissue sensitivity to insulin in diabetic rats. J Clin Invest 79:1510-1515, 1987
21. Kahn BB, Shulman GI, DeFronzo RA, Cushman SW, Rosseti L: Normalization of blood glucose in diabetic rats with Phlorizin treatment reverses insulin-resistant glucose transport in adipose cells without restoring glucose transport gene expression. J Clin Invest 87:561-570, 1991
22. Blondel O, Bailbe D, Portha B: Insulin resistance in rats with non-insulin-dependent diabetes induced by neonatal (5 days) streptozotocin: evidence for reversal following Phlorizin treatment. Metabolism 39:787-793, 1990
23. Goto Y, Suzuki K-I, Sasaki M, Ono T, Abe S: GK rat as a model of non-obese non-insulin-dependent diabetes: selective breeding over 35 generations. In Frontiers in Diabetes Research. Lessons from Animal Diabetes. Shafrir E, Renold AE, Eds. London, John Libbey, 1988, p. 301-303
24. Krook A, Kawano Y, Song XM, Efendic S, Roth RA, Wallberg-Henriksson H, Zierath JR: Improved glucose tolerance restores insulin-stimulated Akt kinase activity and glucose transport in skeletal muscle from diabetic Goto-Kakizaki (GK) rats. Diabetes 46:2110-2114, 1997
25. Henrikson EJ, Holloszy JO: Effect of diffusion distance on measurement of rat skeletal muscle glucose transport in vitro. Acta Physiol Scand 143:381-386, 1991
26. Wallberg-Henrikson H, Zetan N, Henrikson J: Reversibility of decreased insulin-stimulated glucose transport capacity in diabetic muscle with in vitro incubation: insulin is not required. J Biol Chem 262:7665-7671, 1987
27. Krook A, Whitehead JP, Dobson SP, Griffiths MR, Ouwents M, Baker C, Hayward AC, Sen SK: Two naturally occurring insulin receptor tyrosine kinase domain mutants provide evidence that phosopholinositide 3-kinase activation alone is not sufficient for the meditation of insulin's metabolic and mitogenic effects. J Biol Chem 272:30208-30214, 1997
28. Cross AU, Alessi DAE, Cohen DR, Andjelkovich P, Hemmings BA: Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378:785-789, 1995
29. Krook A, Roth RA, Jiang XJ, Zierath JR, Wallberg-Henriksson H: Insulin-stimulated Akt kinase activity is reduced in skeletal muscle from non-insulin-dependent diabetic subjects. Diabetes 47:1281-1286, 1998
30. Sun XJ, Rothenberg P, Kahn CR, Backer JM, Araki E, Wilden PA, Cahill DA, Goldstein BJ, White MF: Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 352:73-77, 1991
31. Sun XJ, Wang LM, Zhang Y, Yenush L, Myers MG Jr, Glasheen E, Lane WS, Pierce JH, White MF: Role of IRS-2 in insulin and cytokine signalling. Nature 377:173-177, 1995
32. Lavan BE, Lane WS, Lienhard GE: The 60-kDa phosphotyrosine protein in insulin-treated adipocytes is a new member of the insulin receptor substrate family. J Biol Chem 272:11439-11443, 1997
33. Smith-Hall J, Pons S, Patti ME, Burks DJ, Yenush L, Sun XJ, Kahn CR, White MF: The 60 kDa insulin receptor substrate functions like an IRS protein (pp60IRS3) in adipose cells. Biochemistry 36:8304-8310, 1997
34. Lavan BE, Fantin VR, Chang ET, Lane WS, Keller SR, Lienhard GE: A novel 160-kDa phosphotyrosine protein in insulin-treated embryonic kidney cells is a new member of the insulin receptor substrate family. J Biol Chem 272:21403-21407, 1997
35. Patti ME, Sun XJ, Bruening JC, Araki E, Lipes MA, White MF, Kahn CR: 4PS/insulin receptor substrate (IRS)-2 is the alternative substrate of the insulin receptor in IRS-1-deftcient mice. J Biol Chem 270:24670-24673, 1995
36. Tobe K, Tamemoto H, Yamauchi T, Aizawa S, Yazaki Y, Kadowaki T: Identification of a 190-kDa protein as a novel substrate for the insulin receptor kinase functionally similar to insulin receptor substrate-1. J Biol Chem 270:5698-5701, 1995
37. Kerouz NJ, Horsch D, Pons S, Kahn CR: Differential regulation of insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse. J Clin Invest 100:3164-3172, 1997
38. Kohn AD, Summers SA, Birnbaum MJ, Roth RA: Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J Biol Chem 271:31372-31378, 1996
39. Tanti JF, Grillo S, Gremeaux T, Coffer PJ, Van Obberghen E, Le Marchand-Brustel Y: Potential role of protein kinase B in glucose transport 4 translocation in adipocytes. Endocrinol 138:2005-2010, 1997
40. Ueki K, Yamamoto-Honda R, Kaburagi Y, Yamauchi T, Tobe K, Burgering BMT, Coffer PJ, Komuro I, Akanuma Y, Yazaki Y, Kadowaki T: Potential role of protein kinase B in insulin-induced glucose transport, glycogen synthesis, and protein synthesis. J Biol Chem 273:5315-5322, 1998
41. Hajduch E, Alessi DR, Hemmings BA, Hundal HS: Constitutive activation of protein kinase Bα by membrane targeting promotes glucose and system A amino acid transport, protein synthesis, and inactivation of glycogen synthase kinase 3 in L6 muscle cells. Diabetes 47:1006-1013, 1998
42. Kitamura T, Ogawa W, Sakaue H, Hino Y, Kuroda S, Takata M, Matsumoto M, Maeda T, Konishi H, Kikkawa U, Kasuga M: Requirement for activation of the serine-threonine kinase Akt (protein kinase B) in insulin stimulation of protein synthesis but not glucose transport. Mol Cell Biol 18:3708-3717, 1998
43. Summers SA, Garza LA, Zhou H, Brinbaum MJ: Regulation of insulin-stimulated glucose transporter GLUT4 translocation and Akt kinase activity by ceramide. Mol Cell Biol 18:5457-5464, 1998
44. Henry RR, Wallace P, Olefsky JM: Effects of weight loss on mechanisms of hyperglycemia in obese non-insulin-dependent diabetes mellitus. Diabetes 35:990-998, 1986
45. Friedman JE, Dohm GL, Leggett-Frazier N, Elton CW, Tapscott EB, Portes WJ, Caro JF: Restoration of insulin responsiveness in skeletal muscle of morbidly obese patients after weight loss. J Clin Invest 89:701-705, 1992
46. Kolterman OG, Gray RS, Shapiro G, Scarlett JA, Griffin J, Olefsky JM: The acute and chronic effects of sulfonylurea therapy in type II diabetic subjects. Diabetes 33:346-354, 1984
47. Greenfield H, Doberne L, Rosenthal M, Schulz B, Widstrom A, Reaven GM: Effect of sulfonylurea treatment on in vivo insulin secretion and action in patients with non-insulin-dependent diabetes mellitus. Diabetes 31:307-312, 1982
48. Ginsberg H, Rayfield EJ: Effect of insulin therapy on insulin resistance in type II diabetic subjects: evidence for heterogeneity. Diabetes 30:739-745, 1981
49. Garvey WT, Olefsky JM, Griffin J, Hamman RF, Kolterman OG: The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus. Diabetes 34:222-234, 1985
50. Zierath JR, Galuska D, Nolte LA, Thörne A, Smedegaard K, Wallberg-Henriksson H: Effects of glycemia on glucose transport in isolated skeletal muscle from patients with NIDDM: in vitro reversal of muscular insulin resistance. Diabetologia 37:270-277, 1994